Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-alcoholic Steatohepatitis (MASH)”

41 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 41 results

Testing effectiveness (Phase 2)Study completedNCT06342947
What this trial is testing

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Who this might be right for
NASHMASHMetabolic Dysfunction-Associated Steatohepatitis+1 more
Aligos Therapeutics 102
Large-scale testing (Phase 3)Active Not RecruitingNCT06161571
What this trial is testing

A Study Evaluating Efruxifermin in Subjects With Non-invasively Diagnosed Nonalcoholic Steatohepatitis (NASH)/Metabolic Dysfunction-Associated Steatohepatitis (MASH) and Nonalcoholic Fatty Liver Disease (NAFLD)/Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
NASH/MASHNAFLD/MASLD
Akero Therapeutics, Inc 700
Not applicableStudy completedNCT05765890
What this trial is testing

Barriers to MASLD Management in Europe: Findings From a Multidisciplinary HCP-survey

Who this might be right for
Non-alcoholic Steatohepatitis (MASH)Non-alcoholic Fatty Liver Disease (MASLD)
Novo Nordisk A/S 675
Not applicableLooking for participantsNCT07330830
What this trial is testing

Study of PNPLA3 Genetic Polymorphisms in Patients With Non-Alcoholic Fatty Liver Disease in an Ultramarine Population (AdipoDROMExpo)

Who this might be right for
MASLD/MASH (Metabolic Dysfunction-Associated Steatotic Liver Disease / Metabolic Dysfunction-Associated Steatohepatitis)
Centre Hospitalier Universitaire de la Guadeloupe 600
Testing effectiveness (Phase 2)Active Not RecruitingNCT07024212
What this trial is testing

Phase II Study Evaluating the Efficacy and Safety of DR10624 Injection in MASLD and MetALD Subjects

Who this might be right for
MASLD
Zhejiang Doer Biologics Co., Ltd. 110
Large-scale testing (Phase 3)Looking for participantsNCT06318169
What this trial is testing

A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH) With Fibrosis
89bio, Inc. 1,350
Large-scale testing (Phase 3)WithdrawnNCT06594523
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASH and F2/F3 Fibrosis

Who this might be right for
MASHNASHMetabolic Dysfunction-associated Steatohepatitis+3 more
Sagimet Biosciences Inc.
Testing effectiveness (Phase 2)Looking for participantsNCT05648214
What this trial is testing

A Trial to Learn if ALN-PNP is Safe and Well Tolerated in Healthy Adults and Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)

Who this might be right for
Healthy VolunteersMetabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 172
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07527910
What this trial is testing

A Phase 2a Study of ALN-PNP With and Without a GLP1R Agonist in Adult Patients With Homozygous PNPLA3-Related MASLD

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Regeneron Pharmaceuticals 204
Post-approval studies (Phase 4)Looking for participantsNCT06523530
What this trial is testing

Effect of a GnRH Analog on Hepatic Steatosis

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver DiseaseNonalcoholic Fatty LiverEndometriosis
Aristotle University Of Thessaloniki 62
Large-scale testing (Phase 3)WithdrawnNCT06692283
What this trial is testing

Study Evaluating the Safety and Efficacy of Denifanstat in Patients With MASLD and MASH

Who this might be right for
MASLDMASHNASH+4 more
Sagimet Biosciences Inc.
Large-scale testing (Phase 3)Looking for participantsNCT06632444
What this trial is testing

LIVERAGE™: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Moderate or Advanced Liver Fibrosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis (MASH)Liver Fibrosis
Boehringer Ingelheim 1,800
Post-approval studies (Phase 4)Looking for participantsNCT06374875
What this trial is testing

Fibrosis Lessens After Metabolic Surgery

Who this might be right for
Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)Non-Alcoholic Fatty Liver DiseaseMetabolic Dysfunction-Associated Steatohepatitis (MASH)+2 more
Ali Aminian 120
Not applicableLooking for participantsNCT06138821
What this trial is testing

Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial

Who this might be right for
ObesityLiver DiseasesLiver Fibrosis+16 more
Pichamol Jirapinyo, MD, MPH 132
Not applicableNot Yet RecruitingNCT07336563
What this trial is testing

ENDOCARE-SCREEN: Metabolic Liver Dysfunction Screening Study

Who this might be right for
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASH) / Nonalcoholic Steatohepatitis (NASH)Metabolic SyndromeObesity & Overweight+2 more
Jarosław Drobnik 10,000
Large-scale testing (Phase 3)Looking for participantsNCT07221227
What this trial is testing

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 1,200
Testing effectiveness (Phase 2)Looking for participantsNCT07288138
What this trial is testing

A Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)

Who this might be right for
Metabolic Dysfunction-associated Steatohepatitis
Eccogene 160
Large-scale testing (Phase 3)Looking for participantsNCT06632457
What this trial is testing

LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have Cirrhosis

Who this might be right for
Metabolic Dysfunction Associated Steatohepatitis
Boehringer Ingelheim 1,590
Early research (Phase 1)Looking for participantsNCT06947304
What this trial is testing

Evaluation of Miricorilant on Liver Fat in Patients With MASLD

Who this might be right for
Nonalcoholic Steatohepatitis (NASH)Metabolic Dysfunction-Associated Steatohepatitis (MASH)Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)+1 more
Corcept Therapeutics 8
Testing effectiveness (Phase 2)Looking for participantsNCT07308548
What this trial is testing

A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Who this might be right for
NAFLD (Non-alcoholic Fatty Liver Disease)
Hinova Pharmaceuticals Inc. 80
Load More Results